My child has ADHD: Medication or Meditation? Mindfulness training versus medication in the treatment of childhood ADHD

ADHD: Medication or Meditation?

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2013-003888-59-NL

Enrollment

120

Registered

2014-01-17

Start date

2014-03-17

Completion date

Unknown

Last updated

2014-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention Deficit Hyperactivity Disorder (ADHD)

Interventions

Trade Name: Ritalin (methylphenidate) Product Name: Ritalin Product Code: RVG 03957 Pharmaceutical Form: Tablet

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - The child is between 9 and 18 years of age - The child has a DSM classification of ADHD - ADIS-C is administered - (Estimated) IQ > 80 - At least one parent is willing to participate in the Mindful Parenting training Are the trial subjects under 18? yes Number of subjects for this age range: 120 F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: - (Estimated) IQ < 80 - Suicidal ideation - Suffering from psychosis or schizophrenia - Co-morbid autism or Conduct Disorder - Current or previous use of methylphenidate - Participation in a currently active other psychological intervention

Design outcomes

Primary

Measure	Time frame
Main Objective: The main objective of this trial is to study the effects of mindfulness training combined with Mindful Parenting training versus methylphenidate in children and youngsters with ADHD on outcome measures of attention, hyperactivity and impulsivity.;Secondary Objective: A seondary aim of this study is to evaluate the cost-effectiveness of mindfulness training + Mindful Parenting training as compared to methylphenidate in this group of children.;Primary end point(s): Our primary outcome measure is attention, hyperactivity and impulsivity in the child.;Timepoint(s) of evaluation of this end point: Directly after the last participant finished his/her treatment	—

Measure

Time frame

Main Objective: The main objective of this trial is to study the effects of mindfulness training combined with Mindful Parenting training versus methylphenidate in children and youngsters with ADHD on outcome measures of attention, hyperactivity and impulsivity.;Secondary Objective: A seondary aim of this study is to evaluate the cost-effectiveness of mindfulness training + Mindful Parenting training as compared to methylphenidate in this group of children.;Primary end point(s): Our primary outcome measure is attention, hyperactivity and impulsivity in the child.;Timepoint(s) of evaluation of this end point: Directly after the last participant finished his/her treatment

—

Secondary

Measure	Time frame
Secondary end point(s): Secondary outcome measures are symptoms of anxiety and depression, sleep, parents own symptomatology, parental stress and mindfulness. ;Timepoint(s) of evaluation of this end point: Directly after the last participant finished his/her treatment	—

Countries

Netherlands

Contacts

Public ContactResearch Institute

University of Amsterdam

e.i.debruin@uva.nl0031205251262

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026